[Edaily Reporter Kwon Oh-seok] #A-Root has begun raising funds to expand its stablecoin business. (Photo: A-Root) On the 16th, A-Root announced that it has decided to conduct a third-party private placement worth approximately 5 billion won targeting its largest shareholder and specific investors. The issue price is 4,660 won, and a total of 1,072,960 new common shares will be issued. The largest shareholder and Next Fund No. 2 will participate in this capital increase, and following the completion of the transaction, the largest shareholder’s stake is expected to increase from the current 17.4% to 22.2%. The funds raised are planned to be used as operating capital, including for new businesses related to stablecoins. The company explained that since it has already obtained the necessary business licenses from overseas financial authorities, the foundation has been laid to accelerate the pace of business development. An A-Root official stated, “The largest shareholder’s participation is intended to demonstrate to the market their confidence in the new business and their commitment to responsible management,” adding, “External investors also participated in the investment after highly evaluating the company’s future growth potential.” The official further noted, “Based on the secured funds, we will pursue both existing businesses and digital asset-based ventures in parallel to achieve tangible results in our global market expansion.” Previously, A-Root obtained official approval from the Astana Financial Services Authority (AFSA) in Kazakhstan to issue and operate stablecoins through its proprietary digital financial platform, “FORTA.” It is understood that this authorization is granted on a limited basis only to companies with the regulatory compliance capabilities and business stability to meet the requirements. The Astana International Financial Centre (AIFC) is a financial special zone established to attract fintech and digital asset companies, featuring an independent regulatory environment based on the UK legal system. As of the first half of last year, it was home to approximately 4,000 companies from 85 countries, with cumulative investment reaching approximately $16.9 billion.
As the prolonged period of high interest rates increases the refinancing burden on companies, warning signs of credit rating downgrades have emerged, particularly in sectors experiencing sluggish busi…
On the streets of Hongdae, where morning temperatures had dropped below freezing, one building was bathed entirely in pink. People wearing down jackets with hoods pulled tight lined up along the wall,…
#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…